Journal of Pharmacogenomics & Pharmacoproteomics

Personalizing the benefit risk assessment when prescribing medicines - Doing more with less

4^th International conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics

September 22-23, 2016 Phoenix, USA

Gregory Fiore

Fiore Healthcare Advisors, USA

Scientific Tracks Abstracts: J Pharmacogenomics Pharmacoproteomics

Abstract:

Biography :

Dr. Fiore was class valedictorian at New York Medical College. He subsequently trained in Internal Medicine at Harvard Medical School's Brigham and Women's Hospital and then underwent further clinical training in Pulmonary and Critical Care Medicine in the Harvard Pulmonary and Critical Care fellowship program. From Harvard Greg joined McKinsey & Company where he worked in a variety of industries including pharmaceuticals. From McKinsey Greg joined the pharmacovigilance department at Abbott Laboratories where he was responsible for several cardiovascular and metabolic products. Greg joined The Medicines Company as the Head of Global Drug Safety, and later spent time as Head of Alliance Management and as Sr. Director of corporate development/New Business Ventures. Also at The Medicines Company Greg ran a Phase II development program for an acute heart failure therapy.

Email: greg@ssistrategy.com